dry eye syndrome
Ophthalmology · 2007–2025
13decisions
9medicines
1carried consumer input
0individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| polyethylene glycol 400 with propylene glycol Treatment of severe dry eye syndrome. The submission requested listing a new 28 x 0.8 mL unit dose pack size as a cost-minimisation alternative to the existing… | Nov 2025 | Recommended | input received |
| propylene glycol Treatment of severe dry eye syndrome. Systane Balance is an emulsion containing propylene glycol 0.6%w/v that provides temporary relief of burning and… | Jul 2024 | Recommended with restriction | none received |
| hyaluronic acid with polyethylene glycol 400 with propylene glycol with hydroxypropyl guar Treatment of severe dry eye syndrome in patients who are sensitive to preservatives in multi-dose eye drops. | May 2023 | Recommended with restriction | none received |
| polyethylene glycol 400 with propylene glycol Treatment of severe dry eye syndrome, including Sjogren's syndrome. | Jul 2022 | Recommended | none received |
| hypromellose Treatment of severe dry eye syndrome, including Sjogren's syndrome. Temporary relief of symptoms due to dry eye such as burning, irritation and discomfort. | Jul 2021 | Recommended | unclear |
| polyethylene glycol 400 with propylene glycol Severe dry eye syndrome in patients sensitive to preservatives in multi-dose eye drops. | Nov 2021 | Recommended | none received |
| cationic ophthalmic emulsion, preservative free Treatment of severe dry eye syndrome in patients who are sensitive to preservatives in multi-dose eye drops. | Jul 2020 | Recommended with restriction | none received |
| carmellose sodium; hypromellose Treatment of severe dry eye syndrome in patients who are sensitive to preservatives in multi-dose eye drops. | Jul 2019 | Recommended with restriction | none received |
| carmellose sodium; hypromellose Treatment of severe dry eye syndrome in patients who are sensitive to preservatives in multi-dose eye drops. | Jul 2018 | Recommended with restriction | none received |
| hypromellose Severe dry eye syndrome, including Sjögren's syndrome. | Nov 2018 | Recommended with restriction | no section in document |
| ocular lubricants (multiple active ingredients) Dry eye syndrome. PBAC reviewed pricing and equivalence of ocular lubricants including preservative-containing and preservative-free multi-dose and single-dose… | Nov 2014 | Recommended | no section in document |
| tamarindus indica seed polysaccharide Treatment of severe dry eye syndrome, including Sjogren's syndrome, in patients who are sensitive to preservatives in multi-dose eye drops. | Jul 2007 | Recommended with restriction | no section in document |
| tamarindus indica seed polysaccharide (TSP) Severe dry eye syndrome, including Sjogren's syndrome, in patients who are sensitive to preservatives in multi-dose eye drops. | Jul 2007 | Recommended with restriction | no section in document |
What the PBS pays
$31M in government benefit over 2024–25, across 1,854,068 services.
This is spend on the medicines considered for this condition, not spend on the disease. A medicine used for several conditions is counted in full under each, so figures across conditions add to more than national PBS expenditure.
| Medicine | Government benefit |
|---|---|
| hyaluronic acid with polyethylene glycol 400 with propylene glycol with hydroxypropyl guar | $8.9M |
| polyethylene glycol 400 with propylene glycol | $8.9M |
| propylene glycol | $8.9M |
| carmellose sodium; hypromellose | $2.3M |
| hypromellose | $2.3M |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 11 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.